Rationale for and approach to preoperative opioid weaning: a preoperative optimization protocol

por McAnally, Heath
Publicado 2017

Guilty until proven innocent?

por McAnally, Heath B
Publicado 2022

Response to Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth”

por McAnally, Heath B., Bonnet, Udo
Publicado 2021

Comment on “Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update”

por Bonnet, Udo, McAnally, Heath, Scherbaum, Norbert
Publicado 2021

Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth

por McAnally, Heath, Bonnet, Udo, Kaye, Alan D.
Publicado 2020

Correction to: Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth

por McAnally, Heath, Bonnet, Udo, Kaye, Alan D.
Publicado 2020

Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor?

por Claus, Benedikt Bernd, Specka, Michael, McAnally, Heath, Scherbaum, Norbert, Schifano, Fabrizio, Bonnet, Udo
Publicado 2020

Ranking the Harm of Psychoactive Drugs Including Prescription Analgesics to Users and Others–A Perspective of German Addiction Medicine Experts

por Bonnet, Udo, Specka, Michael, Soyka, Michael, Alberti, Thomas, Bender, Stefan, Grigoleit, Torsten, Hermle, Leopold, Hilger, Jörg, Hillemacher, Thomas, Kuhlmann, Thomas, Kuhn, Jens, Luckhaus, Christian, Lüdecke, Christel, Reimer, Jens, Schneider, Udo, Schroeder, Welf, Stuppe, Markus, Wiesbeck, Gerhard A., Wodarz, Norbert, McAnally, Heath, Scherbaum, Norbert
Publicado 2020